Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!

Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!

Bibliographic Details
Main Authors:	Onkardeep Kaur, Pawan Kumar Singh
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Lung India
Online Access:	http://www.lungindia.com/article.asp?issn=0970-2113;year=2023;volume=40;issue=5;spage=483;epage=483;aulast=Kaur

Similar Items

Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study
by: Shambo Samrat Samajdar, et al.
Published: (2023-01-01)

Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

Controlled trial of budesonide–formoterol as needed for mild asthma
by: Beasley, R, et al.
Published: (2019)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
by: Bafadhel, M, et al.
Published: (2018)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
by: Sergey K. Zyryanov, et al.
Published: (2022-08-01)

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
by: Andersson Eva, et al.
Published: (2009-02-01)

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
by: Pavord, I, et al.
Published: (2009)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)

Stepped treatment algorithm using budesonide-formoterol for chronic respiratory diseases: A single arm interventional study.
by: Wan-Chun Huang, et al.
Published: (2022-01-01)

Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
by: Konstantinos P. Exarchos, et al.
Published: (2022-06-01)

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study
by: Edward C. Portillo, et al.
Published: (2023-04-01)

A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
by: Narongwit Nakwan, et al.
Published: (2022-07-01)

An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing
by: L Meyer, et al.
Published: (2003-05-01)

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
by: Trigueros JA, et al.
Published: (2022-11-01)

Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
by: Ratoe Suraya, et al.
Published: (2022-06-01)

A US database study characterizing patients initiating a budesonide–formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease
by: Kern DM, et al.
Published: (2014-07-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
by: Brightling, C, et al.
Published: (2000)

Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
by: Nan Shang, et al.
Published: (2024-12-01)

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow
by: Bärbel Huber, et al.
Published: (2022-07-01)

Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study
by: Bantje Theo A, et al.
Published: (2006-12-01)

A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
by: Chew Keng, Sheng
Published: (2012)

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy
by: Edson Alves de Lima Junior, et al.
Published: (2024-01-01)

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
by: Strange C, et al.
Published: (2023-10-01)

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
by: Bafadhel M, et al.
Published: (2022-12-01)

High-dose budesonide for early COVID-19 - Authors' reply
by: Hobbs, FDR, et al.
Published: (2021)

Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
by: I. N. Trofimenko, et al.
Published: (2020-08-01)

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Reply: budesonide.
by: Sandborn, W, et al.
Published: (2013)

A randomized controlled trial on the use of Budesonide/formoterol (symbicortr) as an alternative Reliever medication for mild to moderate asthmatic attack in Adult patients in emergency department, hospital universiti Sains malaysia
by: Kamarudin, Hamizah
Published: (2012)

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy
by: Buhl Roland, et al.
Published: (2012-07-01)

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
by: O.I. Simonova
Published: (2010-01-01)

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
by: O.I. Simonova
Published: (2010-05-01)

Asset pricing and expected inflation
by: Stulz, Ren M.
Published: (2009)

Recent and expected inflation trends
by: A. J. Jacobs
Published: (1976-11-01)

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
by: de Nigris E, et al.
Published: (2022-11-01)

Cough Syncope in the Times of COVID-19
by: Sadaf Sheikh
Published: (2022-03-01)